Harnessing machine learning for development of microbiome therapeutics

References

• Rosa BA, Mihindukulasuriya K, Hallsworth-Pepin K, Wollam A, Martin J, Snowden C, et al. Improving characterization of understudied human microbiomes using targeted phylogenetics [Article]. mSystems. 2020;5:1. doi:10.1128/mSystems.00096-20.
   Google Scholar
• Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65. doi: 10.1038/nature08821.
   Google Scholar
• Singer-Englar T, Barlow G, Mathur R. Obesity, diabetes, and the gut microbiome: an updated review. Expert Rev Gastroenterol Hepatol. 2019 Jan;13(1):3–20. doi:10.1080/17474124.2019.1543023.
   Google Scholar
• Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, et al.  Parkinson’s disease: the emerging role of gut dysbiosis, antibiotics, probiotics, and fecal microbiota transplantation. J Neurogastroenterol Motil. 2019 Jul 1;530(1–2):363–376. doi:10.5056/jnm19044.
   Google Scholar
• Yadav V, Varum F, Bravo R, Furrer E, Bojic D, Basit AW. Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets. Transl Res. 2016 Oct;176:38–68. doi:10.1016/j.trsl.2016.04.009.
   Google Scholar
• Gao L, Xu T, Huang G,Jiang S, Gu Y, Chen F. Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell. 2018 May;9(5):488–500. doi:10.1007/s13238-018-0548-1.
   Google Scholar
• Ercolini D, Fogliano V. Food design to feed the human gut microbiota. J Agric Food Chem. 2018;66(15):3754–3758. doi:10.1021/acs.jafc.8b00456.
   Google Scholar
• Ezra-Nevo G, Henriques SF, Ribeiro C. The diet-microbiome tango: how nutrients lead the gut brain axis. Curr Opin Neurobiol. 2020 [2020/06/01/];62:122–132. doi:10.1016/j.conb.2020.02.005.
   Google Scholar
• Valdes AM, Walter J, Segal E,Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179. doi:10.1136/bmj.k2179.
   Google Scholar
• Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R,Goodman AL. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019;570(7762):462–467. doi:10.1038/s41586-019-1291-3.
   Google Scholar
• Clarke G, Sandhu KV, Griffin BT,Dinan TG, Cryan JF, Hyland NP. Gut reactions: breaking down xenobiotic-microbiome interactions. Pharmacol Rev. 2019 Apr;71(2):198–224. doi:10.1124/pr.118.015768.
   Google Scholar
• Huttenhower C, Gevers D, Knight R, Abubucker S, Badger JH, Chinwalla AT, et al. Structure, function and diversity of the healthy human microbiome. Nature. 2012 2012/06/01;486(7402):207–214.doi: 10.1038/nature11234.
   Google Scholar
• Proctor LM, Creasy HH, Fettweis JM, Lloyd-Price J, Mahurkar A, Zhou W, et al. The integrative human microbiome project. Nature. 2019 2019/05/01;569(7758):641–648.doi: 10.1038/s41586-019-1238-8.
   Google Scholar
• Human Microbiome HMPNIH. Project. Maryland, USA: National Institutes of Health (NIH); 2020.
   Google Scholar
• EuPathDB. MicrobiomeDB. USA: National. Institute of Allergy and Infectious Diseases (NIAD); 2020.
   Google Scholar
• China National GeneBank. Microbiome Database. Shenzhen (China): China National GeneBank; 2020.
   Google Scholar
• Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6(2):94–98. doi:10.7861/futurehosp.6-2-94. doi: 10.7861/futurehosp.6-2-94.
   Google Scholar
• Camacho DM, Collins KM, Powers RK,Costello JC, Collins JJ. Next-generation machine learning for biological networks [review]. Cell. 2018;173(7):1581–1592. doi:10.1016/j.cell.2018.05.015
   Google Scholar
• Namkung J. Machine learning methods for microbiome studies. J Microbiol. 2020 Mar;58(3):206–216. doi:10.1007/s12275-020-0066-8.
   Google Scholar
• Vujkovic-Cvijin I, Sklar J, Jiang L,Natarajan L, Knight R, Belkaid Y. Host variables confound gut microbiota studies of human disease. Nature. 2020 Nov;587(7834):448–454. doi:10.1038/s41586-020-2881-9.
   Google Scholar
• Google. A history of machine learning 2020 [Accessed 20th October 2020]. Available from: https://cloud.withgoogle.com/build/data-analytics/explore-history-machine-learning/
   Google Scholar
• Badillo S, Banfai B, Birzele F, Davydov II, Hutchinson L, Kam‐Thong T, Siebourg‐Polster J, Steiert B, Zhang JD. An introduction to machine learning. . Clinical Pharmacology & Therapeutics. 2020 Apr;;107(4):871–885. doi:10.1002/cpt.1796.
   Google Scholar
• Neftci EO, Averbeck BB. Reinforcement learning in artificial and biological systems. Nature Machine Intelligence. 2019/03/01 2019;1(3):133–143. doi:10.1038/s42256-019-0025-4.
   Google Scholar
• Sledge IJ, Príncipe JC, editors. Balancing exploration and exploitation in reinforcement learning using a value of information criterion. 2017 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP); 2017 5–9 March 2017. doi:10.1109/ICASSP.2017.7952670.
   Google Scholar
• Silver D, Schrittwieser J, Simonyan K, Antonoglou I, Huang A, Guez A, et al. Mastering the game of Go without human knowledge. Nature. 2017 2017/10/01;550(7676):354–359. doi: 10.1038/nature24270
   Google Scholar
• Cammarota G, Ianiro G, Ahern A, Carbone C, Temko A, Claesson MJ, et al. Gut microbiome, big data and machine learning to promote precision medicine for cancer. Nature reviews gastroenterology & hepatology. 2020; 17:635-648.
   Google Scholar
• ChenM, MaoS, Liu, Y. Big Data:A Survey. Mobile networks and applications. 2014;19(2):171–209. https://doi.org/10.1007/s11036-013-0489-0.
   Google Scholar
• Tang Q, Jin G, Wang G, Liu T, Liu X, Wang B, et al. Current sampling methods for gut microbiota: a call for more precise devices. Front Cell Infect Microbiol. 2020;10:151. doi:10.3389/fcimb.2020.00151.
   Google Scholar
• Vuik F, Dicksved J, Lam SY, Fuhler GM, van der Laan L, van de Winkel A, et al. Composition of the mucosa-associated microbiota along the entire gastrointestinal tract of human individuals. United European Gastroenterol J. 2019 Aug;7(7):897–907. doi:10.1177/2050640619852255.
   Google Scholar
• James KR, Gomes T, Elmentaite R, Kumar N, Gulliver EL, King HW, et al. Distinct microbial and immune niches of the human colon. Nat Immunol. 2020 Mar;21(3):343–353. doi: 10.1038/s41590-020-0602-z.
   Google Scholar
• Parmanand BA, Kellingray L, Le Gall G, Basit AW, Fairweather-Tait S, Narbad A. A decrease in iron availability to human gut microbiome reduces the growth of potentially pathogenic gut bacteria; an in vitro colonic fermentation study. J Nutr Biochem. 2019 May;67:20–27. doi:10.1016/j.jnutbio.2019.01.010.
   Google Scholar
• Wang J, Yadav V, Smart AL, Tajiri S, Basit AW. Stability of peptide drugs in the colon. Eur J Pharm Sci. 2015 Oct;78(78):31–36. doi:10.1016/j.ejps.2015.06.018.
   Google Scholar
• Coombes Z, Yadav V, E. McCoubrey L, Freire C, W. Basit A, Conlan RS, et al. Progestogens are metabolized by the gut microbiota: implications for colonic drug delivery. Pharmaceutics. 2020;12(8). doi:10.3390/pharmaceutics12080760.
   Google Scholar
• Chaudhari DS, Dhotre DP, Agarwal DM, Gaike AH, Bhalerao D, Jadhav P, et al. Gut, oral and skin microbiome of indian patrilineal families reveal perceptible association with age. Sci Rep. 2020 ;2020/03/30 10(1):5685. doi: 10.1038/s41598-020-62195-5
   Google Scholar
• Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018 2018/03/01;555(7698):623–628. doi: 10.1038/nature25979
   Google Scholar
• Freire AC, Basit AW, Choudhary R, Piong CW, Merchant HA. Does sex matter? the influence of gender on gastrointestinal physiology and drug delivery. Int J Pharm. 2011 Aug 30;415(1–2):15–28. doi:10.1016/j.ijpharm.2011.04.069.
   Google Scholar
• Dehingia M, Adak A, Khan MR. Ethnicity-influenced microbiota: a future healthcare perspective. Trends Microbiol. 2019/03/01/ 2019;27(3):191–193. doi:10.1016/j.tim.2019.01.002.
   Google Scholar
• So D, Whelan K, Rossi M, Morrison M, Holtmann G, Kelly J, et al.  Dietary fiber intervention on gut microbiota composition in healthy adults: A systematic review and meta-analysis. Am J Clin Nutr. 2018;05/11;107.doi: 10.1093/ajcn/nqy041.
   Google Scholar
• Vujkovic-Cvijin I, Sklar J, Jiang L, Natarajan L, Knight R, Belkaid Y.  Host variables confound gut microbiota studies of human disease. In: Nature. 2020; 587(7834):448-454. doi: 10.1038/s41586-020-2881-9.
   Google Scholar
• Raudys SJ, Jain AK. Small sample size effects in statistical pattern recognition: recommendations for practitioners [article]. IEEE Trans Pattern Anal Mach Intell. 1991;13(3):252–264. doi:10.1109/34.75512.
   Google Scholar
• Lecun Y, Bengio Y, Hinton G. Deep learning [Review]. Nature. 2015;521(7553):436–444. doi:10.1038/nature14539.
   Google Scholar
• Vabalas A, Gowen E, Poliakoff E, Casson AJ.  Machine learning algorithm validation with a limited sample size. PLoS One. 2019;12(3):e0224365. doi:10.1371/journal.pone.0224365.
   Google Scholar
• Cheng M, Cao L, Microbiome Big-Data NK. Mining and applications using single-cell technologies and metagenomics approaches toward precision medicine [review]. Front Genet. 2019; 10: 972. 2019-October-09. doi: 10.3389/fgene.2019.00972.
   Google Scholar
• Cox DR, Kartsonaki C, Keogh RH. Big data: some statistical issues. Stat Probab Lett. 2018 [2018/05/01/];136:111–115. doi:10.1016/j.spl.2018.02.015.
   Google Scholar
• García-Gil D, Luengo J, García S, Herrera F. Enabling smart data: noise filtering in big data classification. Inf Sci (Ny). 2019 . 479:135–152. 2019/04/01/.
   Google Scholar
• Lazer D, Kennedy R, King G, Vespignani A.  The parable of google flu: traps in big data analysis. Science. 2014;343(6176):1203–1205. doi:10.1126/science.1248506.
   Google Scholar
• Anonymous. Not so big. The Economist 2020. Jun 2020;13:S5–S6.
   Google Scholar
• Géron A. Hands-on machine learning with scikit-learn & tensorFlow. First ed. California, USA: O’Reilly; 2017.
   Google Scholar
• Morris TP, White IR, Royston P. Tuning multiple imputation by predictive mean matching and local residual draws. BMC Med Res Methodol. 2014/06/05 2014;14(1):75. doi:10.1186/1471-2288-14-75.
   Google Scholar
• Koprinkova P, Petrova M. Data-scaling problems in neural-network training [Article]. Eng Appl Artif Intell. 1999;12(3):281–296. doi:10.1016/S0952-1976(99)00008-1.
   Google Scholar
• Sharma AK, Jaiswal SK, Chaudhary N, Sharma VK. A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota. Sci Rep. 2017 2017 Aug 29;7(1):9751. doi:10.1038/s41598-017-10203-6.
   Google Scholar
• Noronha A, Modamio J, Jarosz Y, Guerard E, Sompairac N, Preciat G, et al. The virtual metabolic human database: integrating human and gut microbiome metabolism with nutrition and disease. Nucleic Acids Res. 2019 Jan 8;47(D1):D614–D624. doi:10.1093/nar/gky992.
   Google Scholar
• Han W, Ye Y. A repository of microbial marker genes related to human health and diseases for host phenotype prediction using microbiome data. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing. 2019;24:236–247. PMID: 30864326.
   Google Scholar
• Nguyen HT, Phan NYK, Luong HH, Le TP, Tran NC. Efficient discretization approaches for machine learning techniques to improve disease classification on gut microbiome composition data [Article]. Advances in Science, Technology and Engineering Systems. 2020;5(3):547–556. doi:10.25046/aj050368.
   Google Scholar
• Chandrasekaran SN, Ceulemans H, Boyd JD, Carpenter AE. Image-based profiling for drug discovery: due for a machine-learning upgrade? Nat rev drug discov. 2020 Dec 22.doi: 10.1038/s41573-020-00117-w.
   Google Scholar
• Zhou YH, Gallins P. A review and tutorial of machine learning methods for microbiome host trait prediction [Article]. Front Genet. 2019;10(JUN). doi:10.3389/fgene.2019.00579.
   Google Scholar
• Ghyselinck J, Verstrepen L, Moens F, Van den Abbeele P, Said J, Smith B, et al. A 4-strain probiotic supplement influences gut microbiota composition and gut wall function in patients with ulcerative colitis. Int J Pharm. 2020 Jul;587:119648. doi:10.1016/j.ijpharm.2020.119648.
   Google Scholar
• Barlow GM, Yu A, Mathur R. Role of the gut microbiome in obesity and diabetes mellitus. Nutr Clin Pract. 2015 Dec;30(6):787–797. doi:10.1177/0884533615609896.
   Google Scholar
• Rowin J, Xia Y, Jung B, Sun J.Gut inflammation and dysbiosis in human motor neuron disease [Article]. Physiological Reports. 2017;5(18):18. doi:10.14814/phy2.13443.
   Google Scholar
• Moens F, Van den Abbeele P, Basit AW, Dodoo C, Chatterjee R, Smith B, et al.  A four-strain probiotic exerts positive immunomodulatory effects by enhancing colonic butyrate production in vitro. Int J Pharm. 2019. 555:1–10. 2019/01/30/. doi: 10.1016/j.ijpharm.2018.11.020
   Google Scholar
• Pasolli E, Truong DT, Malik F, Waldron L, Segata N. Machine learning meta-analysis of large metagenomic datasets: tools and biological insights [article]. PLoS Comput Biol. 2016;12(7):7. doi:10.1371/journal.pcbi.1004977.
   Google Scholar
• Gupta VK, Kim M, Bakshi U, Cunningham KY, Davis JM, Lazaridis KN, et al. A predictive index for health status using species-level gut microbiome profiling. Nat Commun. 2020;11(1):1. doi:10.1038/s41467-020-18476-8.
   Google Scholar
• Lian X, Yang S, Li H, Fu C, Zhang Z. Machine-learning-based predictor of human-bacteria protein-protein interactions by incorporating comprehensive host-network properties [article]. J Proteome Res. 2019;18(5):2195–2205. doi:10.1021/acs.jproteome.9b00074.
   Google Scholar
• Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015 Nov 19;163(5):1079–1094. doi:10.1016/j.cell.2015.11.001.
   Google Scholar
• Veiga P, Suez J, Derrien M, Elinav E. Moving from probiotics to precision probiotics. Nat Microbiol. 2020 May 11; 5: 878-880. doi: 10.1038/s41564-020-0721-1.
   Google Scholar
• Zhang L, Tan J, Han D, Zhu H. From machine learning to deep learning: progress in machine intelligence for rational drug discovery [Review]. Drug Discov Today. 2017;22(11):1680–1685. doi:10.1016/j.drudis.2017.08.010.
   Google Scholar
• Stephenson N, Shane E, Chase J, Rowland J, Ries D, Justice N, et al. Survey of machine learning techniques in drug discovery [review]. Curr Drug Metab. 2019;20(3):185–193. doi:10.2174/1389200219666180820112457.
   Google Scholar
• Elbadawi M, Gaisford S, Basit AW. Advanced machine-learning techniques in drug discovery. Drug discov today. 2020 Dec 5. doi: 10.1016/j.drudis.2020.12.003
   Google Scholar
• Olivecrona M, Blaschke T, Engkvist O, Chen H. Molecular de-novo design through deep reinforcement learning. J Cheminform. 2017;2017/09/04 9(1):48. doi: 10.1186/s13321-017-0235-x
   Google Scholar
• Chen H, Zhang Z.A Semi-Supervised Method for Drug-Target Interaction Prediction with Consistency in Networks PLoS One. 2013;8:5. doi: 10.1371/journal.pone.0062975.
   Google Scholar
• Bleakley K, Yamanishi Y. Supervised prediction of drug-target interactions using bipartite local models [Article]. Bioinformatics. 2009;25(18):2397–2403. doi:10.1093/bioinformatics/btp433.
   Google Scholar
• Taguchi YH, Iwadate M, Umeyama H. Principal component analysis-based unsupervised feature extraction applied to in silico drug discovery for posttraumatic stress disorder-mediated heart disease [Article]. BMC Bioinform. 2015;16(1):1. doi:10.1186/s12859-015-0574-4.
   Google Scholar
• Zhou H, Gao M, Skolnick J. Comprehensive prediction of drug-protein interactions and side effects for the human proteome. Sci Rep. 2015/06/09 2015;5(1):11090. doi:10.1038/srep11090.
   Google Scholar
• Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018;359(6380):1151. doi:10.1126/science.aao5774.
   Google Scholar
• Byrne CS, Chambers ES, Preston T, Tedford C, Brignardello J, Garcia-Perez I, Holmes E, Wallis GA, Morrison DJ, Frost GS, et al. Effects of Inulin propionate ester incorporated into palatable food products on appetite and resting energy expenditure: A randomised crossover study [Article]. Nutrients. 2019;11(4):4. doi:10.3390/nu11040861.
   Google Scholar
• Koziolek M, Alcaro S, Augustijns P, Basit AW, Grimm M, Hens B, Hoad CL, Jedamzik P, Madla CM, Maliepaard M, et al. The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group. European Journal of Pharmaceutical Sciences. 2019. 134:31–59. 2019/06/15/. doi: 10.1016/j.ejps.2019.04.003
   Google Scholar
• Lam K-L, Cheng W-Y, Su Y, Li X, Wu X, Wong K-H, et al. Use of random forest analysis to quantify the importance of the structural characteristics of beta-glucans for prebiotic development. Food Hydrocolloids. 2020;108.doi: 10.1016/j.foodhyd.2020.106001.
   Google Scholar
• Dodoo CC, Stapleton P, Basit AW, Gaisford S. Use of a water-based probiotic to treat common gut pathogens. Int J Pharm. 2019 Feb;556(556):136–141. doi:10.1016/j.ijpharm.2018.11.075.
   Google Scholar
• Earley H, Lennon G, Balfe A, Coffey JC, Winter DC, O'Connell PR. The abundance of Akkermansia muciniphila and its relationship with sulphated colonic mucins in health and ulcerative colitis. Sci Rep. 2019 Oct 30;9(1):15683. doi:10.1038/s41598-019-51878-3.
   Google Scholar
• Fadda HM. The route to palatable fecal microbiota transplantation. AAPS PharmSciTech. 2020;21(3):3. doi:10.1208/s12249-020-1637-z.
   Google Scholar
• Allegretti J, Eysenbach LM, El-Nachef N, Fischer M, Kelly C, Kassam Z. The current landscape and lessons from fecal microbiota transplantation for inflammatory bowel disease: past, present, and future [review]. Inflamm Bowel Dis. 2017;23(10):1710–1717. doi:10.1097/MIB.0000000000001247.
   Google Scholar
• Allegretti JR, Fischer M, Sagi SV, Bohm ME, Fadda HM, Ranmal SR, et al. Fecal microbiota transplantation capsules with targeted colonic versus gastric delivery in recurrent clostridium difficile infection: a comparative cohort analysis of high and lose dose. Dig Dis Sci. 2019 Jun;64(6):1672–1678. doi:10.1007/s10620-018-5396-6.
   Google Scholar
• Deusch S, Serrano-Villar S, Rojo D, Martínez-Martínez M, Bargiela R, Vázquez-Castellanos JF, et al. Effects of HIV, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota [Article]. AIDS. 2018;32(10):1229–1237. doi:10.1097/QAD.0000000000001831.
   Google Scholar
• Serrano-Villar S, Vázquez-Castellanos JF, Vallejo A, Latorre A, Sainz T, Ferrando-Martínez S, et al. The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects. Mucosal Immunol. 2017 2017/09/01;10(5):1279–1293. doi: 10.1038/mi.2016.122
   Google Scholar
• Daisley BA, Chanyi RM, Abdur-Rashid K, Al KF, Gibbons S, Chmiel JA, et al.  Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients. Nat Commun. 2020 Sep 24;11(1):4822. doi:10.1038/s41467-020-18649-5.
   Google Scholar
• Chambers ES, Byrne CS, Rugyendo A, Morrison DJ, Preston T, Tedford C, et al. The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease. Diabetes Obes Metab. 2019;21(2):372–376. doi:10.1111/dom.13500.
   Google Scholar
• Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SEK, et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;64(11):1744–1754. doi:10.1136/gutjnl-2014-307913.
   Google Scholar
• Langdon A, Crook N, Dantas G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med. 2016;8(1):39. doi:10.1186/s13073-016-0294-z.
   Google Scholar
• Ghose C, Euler CW. Gram-negative bacterial lysins [Review]. Antibiotics. 2020;9(2):2. doi:10.3390/antibiotics9020074.
   Google Scholar
• Aulton ME, Taylor K. Aulton’s pharmaceutics: the design and manufacture of medicines. Edinburgh, United Kingdom: Churchill Livingstone/Elsevier; 2018. English.
   Google Scholar
• McConnell EL, Liu F, Basit AW. Colonic treatments and targets: issues and opportunities. J Drug Target. 2009 Jun;17(5):335–363. doi:10.1080/10611860902839502.
   Google Scholar
• Bak A, Ashford M, Brayden DJ. Local delivery of macromolecules to treat diseases associated with the colon. Adv Drug Deliv Rev. 2018 Nov;136-137:2–27. Dec;136-137. doi:10.1016/j.addr.2018.10.009.
   Google Scholar
• Varum F, Cristina Freire A, Bravo R, Basit AW. OPTICORE, an innovative and accurate colonic targeting technology. Int J Pharm. 2020 Apr;583:119372. doi:10.1016/j.ijpharm.2020.119372.
   Google Scholar
• Varum F, Cristina Freire A, Fadda HM, Bravo R, Basit AW.  A dual pH and microbiota-triggered coating (Phloral(TM)) for fail-safe colonic drug release. Int J Pharm. 2020 Apr;583:119379. doi:10.1016/j.ijpharm.2020.119379.
   Google Scholar
• Damiati SA. digital pharmaceutical sciences. AAPS PharmSciTech. 2020 Jul 26;21(6):206. doi:10.1208/s12249-020-01747-4.
   Google Scholar
• Yang Y, Ye Z, Su Y, Zhao Q, Li X, Ouyang D. Deep learning for in vitro prediction of pharmaceutical formulations. Acta Pharm Sin B. 2019;9(1):177–185. 2019/01/01/. doi:10.1016/j.apsb.2018.09.010.
   Google Scholar
• Lusci A, Pollastri G, Baldi P. Deep architectures and deep learning in chemoinformatics: the prediction of aqueous solubility for drug-like molecules [Article]. J Chem Inf Model. 2013;53(7):1563–1575. doi:10.1021/ci400187y.
   Google Scholar
• Han R, Yang Y, Li X, Ouyang D. Predicting oral disintegrating tablet formulations by neural network techniques. Asian J Pharm Sci. 2018;13(4):336–342. Jul;. doi:10.1016/j.ajps.2018.01.003.
   Google Scholar
• Han R, Xiong H, Ye Z, Yang Y, Huang T, Jing Q, et al.  Predicting physical stability of solid dispersions by machine learning techniques. Journal of Controlled Release. 2019;2019/10/01/;311–312:16–25.doi: 10.1016/j.jconrel.2019.08.030.
   Google Scholar
• Gentiluomo L, Roessner D, Augustijn D, Svilenov H, Kulakova A, Mahapatra S, et al. Application of interpretable artificial neural networks to early monoclonal antibodies development. European Journal of Pharmaceutics and Biopharmaceutics. 2019;2019/08/01/;141:81–89. https://doi.org/10.1016/j.ejpb.2019.05.017.
   Google Scholar
• Li Y, Abbaspour MR, Grootendorst PV, Rauth AM, Wu XY. Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology. European Journal of Pharmaceutics and Biopharmaceutics. 2015;2015/08/01/;94:170–179.https://doi.org/10.1016/j.ejpb.2015.04.028.
   Google Scholar
• Barthus RC, Mazo LH, Poppi RJ. Simultaneous determination of vitamins C, B6 and PP in pharmaceutics using differential pulse voltammetry with a glassy carbon electrode and multivariate calibration tools. J Pharm Biomed Anal. 2005 2005/06//;38(1):94–99. doi:10.1016/j.jpba.2004.12.017.
   Google Scholar
• Ghosh A, Louis L, Arora KK, Hancock BC, Krzyzaniak JF, Meenan P, et al. Assessment of machine learning approaches for predicting the crystallization propensity of active pharmaceutical ingredients [Article]. CrystEngComm. 2019;21(8):1215–1223.doi: 10.1039/C8CE01589A.
   Google Scholar
• Dodoo CC, Wang J, Basit AW, Stapleton P, Gaisford S. Targeted delivery of probiotics to enhance gastrointestinal stability and intestinal colonisation. Int J Pharm. 2017;530(1):224–229. 2017/09/15/. doi:10.1016/j.ijpharm.2017.07.068.
   Google Scholar
• King AC, Woods M, Liu W, Lu Z, Gill D, Krebs MRH. High-throughput measurement, correlation analysis, and machine-learning predictions for pH and thermal stabilities of Pfizer-generated antibodies [Article]. Protein Science. 2011;20(9):1546–1557. doi:10.1002/pro.680.
   Google Scholar
• Singhal A, Roy D, Mittal S, Dhar J, Singh A. A new computational approach to identify essential genes in bacterial organisms using machine learning. Advances in Intelligent Systems and Computing. 2019(p):67–79.doi: 10.1007/978-981-13-1132-1_6.
   Google Scholar
• Lee MW, de Anda J, Kroll C, Bieniossek C, Bradley K, Amrein KE, et al. How do cyclic antibiotics with activity against Gram-negative bacteria permeate membranes? A machine learning informed experimental study [Article]. Biochimica Et Biophysica Acta - Biomembranes. 2020;1862:8. doi:10.1016/j.bbamem.2020.183302.
   Google Scholar
• Khaledi A, Weimann A, Schniederjans M, Asgari E, Kuo TH, Oliver A, et al. Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics. EMBO Mol Med. 2020;12(3):3. doi:10.15252/emmm.201910264.
   Google Scholar
• Luo YM, Liu FT, Chen MX, Tang WL, Yang YL, Tan XL, et al. A machine learning model based on initial gut microbiome data for predicting changes of bifidobacterium after prebiotics consumption [article]. Nan Fang Yi Ke Da Xue Xue Bao (Journal of Southern Medical University). 2018;38(3):251–260. doi: 10.3969/j.issn.1673-4254.2018.03.03.
   Google Scholar
• Goyanes A, Madla CM, Umerji A, Duran Piñeiro G, Giraldez Montero JM, Lamas Diaz MJ, et al. Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: first single-centre, prospective, crossover study in patients [Article]. Int J Pharm. 2019;567. doi: 10.1016/j.ijpharm.2019.118497.
   Google Scholar
• Trenfield SJ, Awad A, Madla CM, Hatton GB, Firth J, Goyanes A, et al.  Shaping the future: recent advances of 3D printing in drug delivery and healthcare [Review]. Expert Opin Drug Deliv. 2019;16(10):1081–1094. doi:10.1080/17425247.2019.1660318.
   Google Scholar
• Awad A, Yao A, Trenfield SJ, Goyanes A, Gaisford S, Basit AW.  3D printed tablets (Printlets) with braille and moon patterns for visually impaired patients [Article]. Pharmaceutics. 2020;12(2):2. doi:10.3390/pharmaceutics12020172.
   Google Scholar
• Elbadawi M, Ong JJ, Pollard TD, Gaisford S, Basit AW. Additive manufacturable materials for electrochemical biosensor electrodes. Adv Funct Mater. 2020. doi:10.1002/adfm.202006407.
   Google Scholar
• Norman J, Madurawe RD, Moore CM, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev 2017 Jan 1;108:39–50. doi: 10.1016/j.addr.2016.03.001
   Google Scholar
• Melocchi A, Briatico-Vangosa F, Uboldi M, Parietti F, Turchi M, von Zeppelin D, et al. Quality considerations on the pharmaceutical applications of fused deposition modeling 3D printing. Int J Pharm. 2021;592:119901. 2021 Jan 5. doi:10.1016/j.ijpharm.2020.119901.
   Google Scholar
• Lim SH, Kathuria H, Tan JJY, Kang L. 3D printed drug delivery and testing systems - a passing fad or the future? Advanced Drug Delivery Reviews. 2018;132:139–168. 2018 Jul. doi:10.1016/j.addr.2018.05.006.
   Google Scholar
• Gioumouxouzis CI, Karavasili C, Fatouros DG. Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies. Drug Discov Today. 2019 Feb;24(2):636–643. doi:10.1016/j.drudis.2018.11.019.
   Google Scholar
• Alhnan MA, Okwuosa TC, Sadia M, Wan KW, Ahmed W, Arafat B. Emergence of 3D printed dosage forms: opportunities and challenges. Pharm Res. 2016 Aug;33(8):1817–1832. doi: 10.1007/s11095-016-1933-1.
   Google Scholar
• Chen G, Xu Y, Chi Lip Kwok P, Kang L. Pharmaceutical applications of 3d printing. Additive Manufacturing. 2020;2020/08/01/;34:101209. https://doi.org/10.1016/j.addma.2020.101209.
   Google Scholar
• Awad A, Fina F, Goyanes A, Gaisford S, Basit AW. 3D printing: principles and pharmaceutical applications of selective laser sintering. Int J Pharm. 2020;586:119594. 2020 Aug 30. doi:10.1016/j.ijpharm.2020.119594.
   Google Scholar
• Franzosa EA, Huang K, Meadow JF, Gevers D, Lemon KP, Bohannan BJM, et al. Identifying personal microbiomes using metagenomic codes. Proceedings of the National Academy of Sciences. 2015;201423854.doi: 10.1073/pnas.1423854112.
   Google Scholar
• Merchant HA, Liu F, Orlu Gul M, Basit AW.  Age-mediated changes in the gastrointestinal tract. Int J Pharm. 2016;512(2):382–395. 2016/10/30/. doi:10.1016/j.ijpharm.2016.04.024.
   Google Scholar
• Hatton GB, Madla CM, Rabbie SC, Basit AW. All disease begins in the gut: influence of gastrointestinal disorders and surgery on oral drug performance. Int J Pharm. 2018 2018 Sep 5;548(1):408–422. doi:10.1016/j.ijpharm.2018.06.054.
   Google Scholar
• Hatton GB, Madla CM, Rabbie SC, Basit AW. Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption. Drug Discov Today. 2019;24(2):417–427. 2019/02/01/. doi:10.1016/j.drudis.2018.11.009.
   Google Scholar
• Capel AJ, Rimington RP, Lewis MP, Christie SDR. 3D printing for chemical, pharmaceutical and biological applications. Nature Reviews Chemistry. 2018 2018/12/01;2(12):422–436. doi:10.1038/s41570-018-0058-y.
   Google Scholar
• Xu X, Awad A, Robles-Martinez P, Gaisford S, Goyanes A, Basit AW. Vat photopolymerization 3D printing for advanced drug delivery and medical device applications. J Control Release 2020 Oct 5.doi: 10.1016/j.jconrel.2020.10.008.
   Google Scholar
• Durga Prasad Reddy R, Sharma V. Additive manufacturing in drug delivery applications: A Review. Int J Pharm. Sep 2020;4:119820. doi: 10.1016/j.ijpharm.2020.119820.
   Google Scholar
• Dodoo CC, Stapleton P, Basit AW, Gaisford S.  The potential of streptococcus salivarius oral films in the management of dental caries: an inkjet printing approach [Article]. Int J Pharm. 2020;591:591. doi:10.1016/j.ijpharm.2020.119962.
   Google Scholar
• Elbadawi M, Gustaffson T, Gaisford S, Basit AW. 3D printing tablets: predicting printability and drug dissolution from rheological data. Int J Pharm. 2020;590:119868. 2020/11/30/. doi:10.1016/j.ijpharm.2020.119868.
   Google Scholar
• Trenfield SJ, Tan HX, Goyanes A, Wilsdon D, Rowland M, Gaisford S, Basit AW. Non-destructive dose verification of two drugs within 3D printed polyprintlets. Int J Pharm. 2020;577:577. doi:10.1016/j.ijpharm.2020.119066.
   Google Scholar
• Elbadawi M, Muniz Castro B, Gavins FKH, Ong JJ, Gaisford S, Perez G, et al. M3DISEEN: A novel machine learning approach for predicting the 3D printability of medicines. Int J Pharm 2020 Sep 20;590:119837. doi: 10.1016/j.ijpharm.2020.119837
   Google Scholar
• Perez GIP, Gao Z, Jourdain R, Ramirez J, Gany F, Clavaud C, et al. Body site is a more determinant factor than human population diversity in the healthy skin microbiome [Article]. PLoS One. 2016;11(4):4. doi:10.1371/journal.pone.0151990.
   Google Scholar
• Scheline RR. Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacol Rev. 1973;25:451. https://doi.org/10.1002/jps.2600571202.
   Google Scholar
• Sousa T, Paterson R, Moore V, Carlsson A, Abrahamsson B, Basit AW. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm. 2008 2008 Nov 03;363(1–2):1–25. doi:10.1016/j.ijpharm.2008.07.009.
   Google Scholar
• Crouwel F, Buiter HJC, de Boer NK. Gut microbiota-driven drug metabolism in inflammatory bowel disease. J Crohns Colitis. 2020 Jul. 11. doi: 10.1093/ecco-jcc/jjaa143
   Google Scholar
• Hitchings R, Kelly KL. Predicting and understanding the human microbiome’s impact on pharmacology. Trends in Pharmacological Sciences. 2019 Jul;40(7):495–505. doi:10.1016/j.tips.2019.04.014.
   Google Scholar
• Koppel N, Bisanz JE, Pandelia M-E, Turnbaugh PJ, Balskus EP. Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins. eLife. 2018;7:7. doi:10.7554/eLife.33953.
   Google Scholar
• van Kessel SP, Frye AK, El-Gendy AO, Castejon M, Keshavarzian A, van Dijk G, El Aidy S. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of parkinson’s disease. Nat Commun. 2019;10(1):310. doi:10.1038/s41467-019-08294-y.
   Google Scholar
• Borrel G, Brugere J-F, Gribaldo S, Schmitz RA, Moissl-Eichinger C. The host-associated archaeome. Nature Reviews. Microbiology. 2020 2020 Jul;18(11):20. doi:10.1038/s41579-020-0407-y.
   Google Scholar
• Sokol H, Leducq V, Aschard H, Pham H-P, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, et al. Fungal microbiota dysbiosis in IBD. Gut. 2017;66(6):1039. doi:10.1136/gutjnl-2015-310746.
   Google Scholar
• Dong Q, Brulc JM, Iovieno A, Bates B, Garoutte A, Miller D, Revanna KV, Gao X, Antonopoulos DA, Slepak VZ, et al. Diversity of bacteria at healthy human conjunctiva [Article]. Investigative Opthalmology & Visual Science. 2011;52(8):5408–5413. doi:10.1167/iovs.10-6939.
   Google Scholar
• Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009;326(5960):1694. doi:10.1126/science.1177486.
   Google Scholar
• Pollard TD, Ong JJ, Goyanes A, Orlu M, Gaisford S, Elbadawi M, Basit AW. Electrochemical biosensors: a nexus for precision medicine. Drug discovery Today. 2020; 31. 2020 Oct. doi:10.1016/j.drudis.2020.10.021.
   Google Scholar
• Palmara G, Frascella F, Roppolo I, Chiappone A, Chiadò A. Functional 3D printing: approaches and bioapplications. Biosens Bioelectron 2020 Nov 24:112849.doi: 10.1016/j.bios.2020.112849.
   Google Scholar
• Beri K. Skin microbiome & host immunity: applications in regenerative cosmetics & transdermal drug delivery. Future Science OA. 2018;4(6):302. doi:10.4155/fsoa-2017-0117.
   Google Scholar
• Whirl-Carrillo M, McDonagh EM, Hebert JM, Gong L, Sangkuhl K, Thorn CF, Altman RB, Klein TE. Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther. 2012 2012/10/01;92(4):414–417. doi:10.1038/clpt.2012.96.
   Google Scholar
• Nava Lara RA, Aguilera-Mendoza L, Brizuela CA, Peña A, Del Rio G. Heterologous machine learning for the identification of antimicrobial activity in human-targeted drugs. Molecules (Basel, Switzerland). 2019 2019 Mar 31;24(7):7. doi:10.3390/molecules24071258.
   Google Scholar
• Zheng S, Chang W, Liu W, Liang G, Xu Y, Lin F. Computational prediction of a new admet endpoint for small molecules: anticommensal effect on human gut microbiota. J Chem Inf Model. 2019 2019 Mar 25;59(3):1215–1220. doi:10.1021/acs.jcim.8b00600.
   Google Scholar
• Ekins S, Puhl AC, Zorn KM, Lane TR, Russo DP, Klein JJ, Hickey AJ, Clark AM. Exploiting machine learning for end-to-end drug discovery and development. Nat Mater. 2019 2019/05/01;18(5):435–441. doi:10.1038/s41563-019-0338-z.
   Google Scholar
• Bhhatarai B, Walters WP, Hop CECA, Lanza G, Ekins S. Opportunities and challenges using artificial intelligence in ADME/Tox. Nat Mater. 2019 2019/05/01;18(5):418–422. doi:10.1038/s41563-019-0332-5.
   Google Scholar
• Walsh J, Gheorghe CE, Lyte JM, van de Wouw M, Boehme M, Dinan TG, et al. 2020. Gut microbiome-mediated modulation of hepatic cytochrome P450 and P-glycoprotein: impact of butyrate and fructo-oligosaccharide-inulin. Journal of Pharmacy and Pharmacology. 2020/04/26; 72: 1072-1081. https://doi.org/10.1111/jphp.13276.
   Google Scholar
• Walsh J, Olavarria-Ramirez L, Lach G, Boehme M, Dinan TG, Cryan JF, Griffin BT, Hyland NP, Clarke G. Impact of host and environmental factors on β-glucuronidase enzymatic activity: implications for gastrointestinal serotonin. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2020 2020/04/01;318(4):G816–G826. doi:10.1152/ajpgi.00026.2020.
   Google Scholar
• Walsh J, Griffin BT, Clarke G, Hyland NP. Drug-gut microbiota interactions: implications for neuropharmacology. . British Journal of Pharmacology. 2018 Dec;;175(24):4415–4429. doi:10.1111/bph.14366.
   Google Scholar
• Zimmermann-Kogadeeva M, Zimmermann M, Goodman AL. Insights from pharmacokinetic models of host-microbiome drug metabolism. Gut Microbes. 2019;11:3, 587-596, DOI:10.1080/19490976.2019.1667724.
   Google Scholar
• Schuhmacher A, Gatto A, Hinder M, Kuss M, Gassmann O. The upside of being a digital pharma player. Drug Discov Today 2020 Jun 15.doi: 10.1016/j.drudis.2020.06.002.
   Google Scholar
• Royal Society Working Group. Dynamics of data science skills: how can all sectors benefit from data science talent? United Kingdom; 2019. URL: https://royalsociety.org/topics-policy/projects/dynamics-of-data-science/.
   Google Scholar
• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in wuhan, china [Article]. The Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5.
   Google Scholar
• Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, china: a descriptive study [Article]. The Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7.
   Google Scholar
• Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A novel coronavirus from patients with pneumonia in China, 2019 [Article]. New England Journal of Medicine. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017.
   Google Scholar
• COVID-19 to plunge global economy into worst recession since world war ii [internet]. the world bank; 2020; 8th June 2020. Available from:https://www.worldbank.org/en/news/press-release/2020/06/08/covid-19-to-plunge-global-economy-into-worst-recession-since-world-war-ii
   Google Scholar
• Mak -K-K, Pichika MR. Artificial intelligence in drug development: present status and future prospects. Drug Discovery Today. 2019 Mar;;24(3):773–780. doi:10.1016/j.drudis.2018.11.014.
   Google Scholar
• Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. Separating host and microbiome contributions to drug pharmacokinetics and toxicity. Science (New York, NY). 2019;363(6427):9931. doi:10.1126/science.aat9931.
   Google Scholar
• Food and Agriculture Organization of the United Nations and World Health Organisation. Guidelines for the evaluation of probiotics in food. London Ontario (Canada); 2002. p. 1–11.
   Google Scholar
• NuBiyota. safety and efficacy of met-3 in obese human subjects: clinicalTrials.gov; 2018 [accessed 3rd April 2020]. Available from: https://clinicaltrials.gov/ct2/show/NCT03660748?id=NCT03660748&draw=2&rank= 1
   Google Scholar
• Zhao M, Shen C, Ma L. Treatment efficacy of probiotics on atopic dermatitis, zooming in on infants: a systematic review and meta-analysis. Int J Dermatol. 2018 2018/06/01;57(6):635–641. doi:10.1111/ijd.13873.
   Google Scholar
• Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, et al. Expert consensus document: the international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics [review]. Nat Rev Gastroenterol Hepatol. 2017;14(8):491–502. doi:10.1038/nrgastro.2017.75.
   Google Scholar
• Hester SN, Mastaloudis A, Gray R, Antony JM, Evans M, Wood SM. Efficacy of an anthocyanin and prebiotic blend on intestinal environment in obese male and female subjects. Journal of Nutrition and Metabolism. 2018;2018:7497260. doi:10.1155/2018/7497260.
   Google Scholar
• Bomhof MR, Parnell JA, Ramay HR, Crotty P, Rioux KP, Probert CS, Jayakumar S, Raman M, Reimer RA. Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial [article]. Eur J Nutr. 2019;58(4):1735–1745. doi:10.1007/s00394-018-1721-2.
   Google Scholar
• Chen PB, Black AS, Sobel AL, Zhao Y, Mukherjee P, Molparia B, Moore NE, Aleman Muench GR, Wu J, Chen W, et al. Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosis. Nat Biotechnol. 2020;38(11):1288–1297. 2020/06//. doi:10.1038/s41587-020-0549-5.
   Google Scholar
• Brody LP, Sahuri-Arisoylu M, Parkinson JR, Parkes HG, So PW, Hajji N, et al. Cationic lipid-based nanoparticles mediate functional delivery of acetate to tumor cells in vivo leading to significant anticancer effects [article]. Int J Nanomedicine. 2017;12:6677–6685. doi:10.2147/IJN.S135968.
   Google Scholar
• Mills S, Ross RP, Hill C. Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology [review]. FEMS Microbiol Rev. 2017;41(1):S129–S153. doi:10.1093/femsre/fux022.
   Google Scholar
• Yadav V, Gaisford S, Merchant HA, Basit AW. Colonic bacterial metabolism of corticosteroids. Int J Pharm. 2013;457(1):268–274. 2013 Nov 30. doi:10.1016/j.ijpharm.2013.09.007.
   Google Scholar
• Basit AW, Lacey LF. Colonic metabolism of ranitidine: implications for its delivery and absorption [article]. Int J Pharm. 2001;227(1–2):157–165. doi:10.1016/S0378-5173(01)00794-3.
   Google Scholar
• Kim D-H. Gut microbiota-mediated drug-antibiotic interactions. Drug Metabolism and Disposition. 2015;43(10):1581. doi:10.1124/dmd.115.063867.
   Google Scholar
• Basit AW, Newton JM, Lacey LF. Susceptibility of the H2-receptor antagonists cimetidine, famotidine and nizatidine, to metabolism by the gastrointestinal microflora. Int J Pharm. 2002 2002/04/26/;237(1–2):23–33. doi:10.1016/S0378-5173(02)00018-2.
   Google Scholar
• Sousa T, Yadav V, Zann V, Borde A, Abrahamsson B, Basit AW. On the colonic bacterial metabolism of azo-bonded prodrugs of 5-aminosalicylic acid. J Pharm Sci. 2014;103(10):3171–3175. 2014/10/01. doi:10.1002/jps.24103.
   Google Scholar
• Yadav V, Varum F, Bravo R, Furrer E, Basit AW. Gastrointestinal stability of therapeutic anti-TNF α IgG1 monoclonal antibodies. Int J Pharm. 2016 2016 Apr 11;502(1–2):181–187. doi:10.1016/j.ijpharm.2016.02.014.
   Google Scholar